RxDoctor Payments DataLook up a doctor →

Mayez El Harake, MD

Medical Oncology · Beckley, WVNPI 1578550679

Payments from drug & device makers

$4,982in general payments, 2019–2025

Across 244 payments — averaging $20.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$579
  • AstraZeneca$510
  • Johnson & Johnson$432
  • Novartis$404
  • Pfizer$371
  • Daiichi Sankyo Inc.$339
  • plus $2K from 39 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.30$579
AstraZeneca(2 entities)13$510
Johnson & Johnson(2 entities)16$432
Novartis30$404
Pfizer24$371
Daiichi Sankyo Inc.19$339
GSK4$194
AbbVie10$191
Astellas Pharma US Inc9$165
Merck8$158
Seagen Inc.7$147
Eisai Inc.3$125
Bristol Myers Squibb6$115
Incyte Corporation3$106
Gilead(2 entities)5$88
Sanofi4$86
Bayer4$67
Ipsen Biopharmaceuticals, Inc2$63
Genentech USA, Inc.4$60
Amgen4$59
Array Biopharma Inc3$57
Springworks Therapeutics, Inc.2$46
Beigene USA, Inc.1$44
Regeneron Healthcare Solutions, Inc.2$42
Takeda Pharmaceuticals U.S.A., Inc.2$39
ADC Therapeutics America, Inc.2$38
Taiho Oncology, Inc.2$36
Agios Pharmaceuticals, Inc.3$34
Stemline Therapeutics Inc.2$32
Foundation Medicine, Inc.2$31
CTI Biopharma Corp.2$31
Rigel Pharmaceuticals, Inc.2$30
Jazz Pharmaceuticals Inc.1$28
AVEO Pharmaceuticals, Inc.2$26
Kyowa Kirin, Inc.1$26
Tersera Therapeutics LLC1$24
Telix Pharmaceuticals1$23
EMD Serono, Inc.1$20
Novocure Inc.1$20
Sobi, Inc1$19
Fennec Pharmaceuticals, Inc.1$18
Puma Biotechnology, Inc.1$15
Lexicon Pharmaceuticals, Inc.1$14
Verastem, Inc.1$14
Exelixis Inc.1$13

How this compares

Too few medical oncology providers in West Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,825,205
Medicare patients
603
Services billed
116,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Beckley

See the full list for West Virginia →

Where these figures come from

Is this you, or does something look wrong? →